We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Belluscura Plc | LSE:BELL | London | Ordinary Share | GB00BD3B8Z11 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.00 | 9.00 | 11.00 | 10.00 | 10.00 | 10.00 | 65,000 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 825k | -18.52M | -0.1100 | -0.91 | 16.84M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/11/2021 09:44 | I’ve looked for info regarding submissions to European and rest of world regulatory clearance, does anyone know if they are pursuing this? | diesel | |
29/11/2021 09:42 | TX givemesunshine Interesting. | maytrees | |
29/11/2021 09:31 | Good morning givemesunshine I agree and also in both for some while now. | maytrees | |
29/11/2021 09:30 | Great news - this market is huge - been here for a while both directly and via TEK, superb | givmesunshine | |
29/11/2021 08:21 | Medicare news was key to USA success | buywell3 | |
29/11/2021 08:19 | Significant milestone achieved by pioneering medical devices firm Belluscura today. All the details here www.linkedin.com/pos | brummy_git | |
29/11/2021 07:27 | Great RNS this morning! | pngasef | |
26/11/2021 11:10 | Not wishing to profit from peoples misery, but covid is going to be with us for a very long time, maybe always, like the flu. This company is operating in a key market, just hoping they can expand the range and complete on all the patents. | diesel | |
26/11/2021 08:54 | Good morning New Covid-19 variant has hit the markets apparently. Hold tight... | maytrees | |
25/11/2021 12:49 | Added at sub 92p. Possibly US holiday today and tomorrow is part of the cause of the share price fall today; all imho. | maytrees | |
25/11/2021 12:41 | Why the fall I wonder? No bad news that is currently discernible. | maytrees | |
24/11/2021 08:44 | Added a few. Yesterday the share price was 95p bid and 105p offer; today 95p bid 99p offer yet the share price is shown as up 2.11% rather than down a tad. Odd? | maytrees | |
24/11/2021 08:33 | Good morning Unusual early trades today - buys so far | maytrees | |
16/11/2021 11:39 | Good morning Continuing interest in BELL today. | maytrees | |
12/11/2021 16:42 | www.voxmarkets.co.uk BELL 37:30 | brummy_git | |
09/11/2021 09:08 | Good morning diesel Agreed. Slow share price gains continue at present. | maytrees | |
08/11/2021 17:12 | I’m here for a while, looks like business is building nicely. Good product, safe market sector, and huge opportunity, what’s not to like. | diesel | |
08/11/2021 15:34 | Unusual to be up 5% in a day though. Mores news soon maybe though we have only just had an excellent trading update? | maytrees | |
08/11/2021 12:17 | Greetings dieselYou may be slightly in profit now | maytrees | |
04/11/2021 21:38 | Bought into this today, sounds like a promising story. | diesel | |
04/11/2021 08:41 | Fabulous trading update from medical devices firm Belluscura today. Saying "demand for its leading X-PLO2R™ portable oxygen concentrator has significantly exceeded expectations." Find out all the latest commentary here. www.linkedin.com/pos | brummy_git | |
04/11/2021 07:40 | Robert Rauker, CEO of Belluscura plc, commented: "Market reception for the X-PLO2R ™ has been positive and initial demand has been very strong. The recent addition of a fifth distributor in North America gives us confidence to substantially expand our manufacturing capacity to meet demand in the coming years. With the Company now poised to exceed the manufacturing and sales targets set at IPO, we can look to the future with confidence." | buywell2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions